Case 1: Faricimab in a high-need neovascular nAMD patient

Dr. Khanani shares the case of a neovascular nAMD patient with high disease activity who achieved significant vision improvement and fluid resolution after switching to faricimab.

EP: 1.Insights on efficacy and safety of faricimab

Now Viewing

EP: 2.Case 1: Faricimab in a high-need neovascular nAMD patient

EP: 3.Case 2: Faricimab in treatment naïve neovascular nAMD patient

EP: 4.Case 3: Faricimab in a neovascular nAMD patient with persistent fluid

Sponsored by Roche